Clinical trials for Penile cancer and germ cell tumors
23 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 3
Penile cancer and germ cell tumors
#NCT05874063
#2022-502426-41-00
Germ cell tumor
None
Systemic Treatment-Naive
Systemic Treatment-Naive
Good prognosis
Intermediate prognosis
18 recruiting sites
Gustave Roussy, Campus du cancer, Grand Paris
Phase 2
Penile cancer and germ cell tumors
#NCT05529251
#2024-514636-25-00
Germ cell tumor
Pure seminoma
Locally Advanced
None
Systemic Treatment-Naive
Testis
Good prognosis
Surgery
Radiotherapy
Chemotherapy
Radiotherapy
11 recruiting sites
Centre Léon Bérard
Phase 2
Penile cancer and germ cell tumors
#NCT01887340
Cohorte 2
Germ cell tumor
Pure seminoma
Locally Advanced
Metastatic
None
Systemic Treatment-Naive
Surgery
Testis
Other
Good prognosis
Chemotherapy
Radiotherapy
1 recruiting site
Gustave Roussy, Campus du cancer, Grand Paris
Phase 2
Penile cancer and germ cell tumors
#NCT01887340
Cohorte 1
Germ cell tumor
Pure seminoma
Localized
None
Systemic Treatment-Naive
Surgery
Testis
Other
Chemotherapy
Radiotherapy
1 recruiting site
Gustave Roussy, Campus du cancer, Grand Paris
Phase 1 / Phase 2
Breast cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Endometrial cancer
Ovarian / Fallopian tubes / Peritoneum cancer
Head and neck cancer
Sarcoma and GIST
Penile cancer and germ cell tumors
#NCT03093116
#2024-512606-25-00
Metastatic
NTRK-1/2/3
1
2
3 or more
Targeted therapy
Systemic Treatment-Naive
4 recruiting sites
Turning Point Therapeutics, Inc.
Phase 1 / Phase 2
Breast cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Endometrial cancer
Ovarian / Fallopian tubes / Peritoneum cancer
Head and neck cancer
Sarcoma and GIST
Penile cancer and germ cell tumors
#NCT03093116
#2024-512606-25-00
Metastatic
NTRK-1/2/3
1
2
3 or more
Immunotherapy
Chemotherapy
Systemic Treatment-Naive
Targeted therapy
4 recruiting sites
Turning Point Therapeutics, Inc.
Phase 1 / Phase 2
Breast cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Endometrial cancer
Ovarian / Fallopian tubes / Peritoneum cancer
Head and neck cancer
Sarcoma and GIST
Thymus cancer
Penile cancer and germ cell tumors
#NCT05118789
Locally Advanced
Metastatic
ROS-1
1
4 recruiting sites
Nuvalent Inc.
Phase 1
1 recruiting site
Phase 1
1 recruiting site